PRGO Q1 2023 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q1 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B+10.0% YoY

Gross Profit

$414M35.0% margin

Operating Income

$49M4.1% margin

Net Income

-$3M-0.3% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+2.3%

Cash Flow

Operating Cash Flow

$19M

Free Cash Flow

-$4M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$11.0B

Total Liabilities

$6.1B

Stockholders' Equity

$4.8B

Cash & Equivalents

$553M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+10.0%
Gross Profit	$414M	$338M	+22.5%
Operating Income	$49M	$22M	+123.5%
Net Income	-$3M	-$2M	-25.0%

Revenue Segments

Consumer Self-Care Americas

$764M65%

Consumer Self-Care International

$418M35%

Geographic Segments

UNITED STATES

$750M63%

Europe

$407M34%

Other Geographical Areas

$24M2%

IRELAND

$7M1%